0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viscosupplementation for Knee Osteoarthritis Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-2T9705
Home | Market Reports | Health | Health Conditions
Global Viscosupplementation for Knee Osteoarthritis Market Insights and Forecast to 2028

Global Viscosupplementation for Knee Osteoarthritis Market Insights and Forecast to 2028

Code: QYRE-Auto-2T9705
Report
January 2022
91 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.

Viscosupplementation for Knee Osteoarthritis Market Statistics 2028

Due to the COVID-19 pandemic, the global Viscosupplementation for Knee Osteoarthritis market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Single Injection accounting for % of the Viscosupplementation for Knee Osteoarthritis global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Viscosupplementation for Knee Osteoarthritis market size is valued at US$ million in 2021, while the US and Europe Viscosupplementation for Knee Osteoarthritis are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Viscosupplementation for Knee Osteoarthritis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Viscosupplementation for Knee Osteoarthritis include Sanofi, Anika Therapeutics, Seikagaku, Zimmer, Bioventus, Ferring, Lifecore Biomedical and LG Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Viscosupplementation for Knee Osteoarthritis Market Segment

Viscosupplementation for Knee Osteoarthritis market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Viscosupplementation for Knee Osteoarthritis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Single Injection
  • Three Injection
  • Five Injection

Segment by Application

  • Hospitals
  • Clinics
  • Others

BY COMPANY

  • Sanofi
  • Anika Therapeutics
  • Seikagaku
  • Zimmer
  • Bioventus
  • Ferring
  • Lifecore Biomedical
  • LG Life Sciences

BY REGION

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E
1 Study Coverage
1.1 Viscosupplementation for Knee Osteoarthritis Product Introduction
1.2 Market by Type
1.2.1 Global Viscosupplementation for Knee Osteoarthritis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Single Injection
1.2.3 Three Injection
1.2.4 Five Injection
1.3 Market by Application
1.3.1 Global Viscosupplementation for Knee Osteoarthritis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Viscosupplementation for Knee Osteoarthritis Sales Estimates and Forecasts 2017-2028
2.2 Global Viscosupplementation for Knee Osteoarthritis Revenue Estimates and Forecasts 2017-2028
2.3 Global Viscosupplementation for Knee Osteoarthritis Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Viscosupplementation for Knee Osteoarthritis Sales by Region
2.4.1 Global Viscosupplementation for Knee Osteoarthritis Sales by Region (2017-2022)
2.4.2 Global Sales Viscosupplementation for Knee Osteoarthritis by Region (2023-2028)
2.5 Global Viscosupplementation for Knee Osteoarthritis Revenue by Region
2.5.1 Global Viscosupplementation for Knee Osteoarthritis Revenue by Region (2017-2022)
2.5.2 Global Viscosupplementation for Knee Osteoarthritis Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Viscosupplementation for Knee Osteoarthritis Sales by Manufacturers
3.1.1 Global Top Viscosupplementation for Knee Osteoarthritis Manufacturers by Sales (2017-2022)
3.1.2 Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Viscosupplementation for Knee Osteoarthritis in 2021
3.2 Global Viscosupplementation for Knee Osteoarthritis Revenue by Manufacturers
3.2.1 Global Viscosupplementation for Knee Osteoarthritis Revenue by Manufacturers (2017-2022)
3.2.2 Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Viscosupplementation for Knee Osteoarthritis Revenue in 2021
3.3 Global Viscosupplementation for Knee Osteoarthritis Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Viscosupplementation for Knee Osteoarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Viscosupplementation for Knee Osteoarthritis Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Viscosupplementation for Knee Osteoarthritis Sales by Type
4.1.1 Global Viscosupplementation for Knee Osteoarthritis Historical Sales by Type (2017-2022)
4.1.2 Global Viscosupplementation for Knee Osteoarthritis Forecasted Sales by Type (2023-2028)
4.1.3 Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2028)
4.2 Global Viscosupplementation for Knee Osteoarthritis Revenue by Type
4.2.1 Global Viscosupplementation for Knee Osteoarthritis Historical Revenue by Type (2017-2022)
4.2.2 Global Viscosupplementation for Knee Osteoarthritis Forecasted Revenue by Type (2023-2028)
4.2.3 Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Type (2017-2028)
4.3 Global Viscosupplementation for Knee Osteoarthritis Price by Type
4.3.1 Global Viscosupplementation for Knee Osteoarthritis Price by Type (2017-2022)
4.3.2 Global Viscosupplementation for Knee Osteoarthritis Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Viscosupplementation for Knee Osteoarthritis Sales by Application
5.1.1 Global Viscosupplementation for Knee Osteoarthritis Historical Sales by Application (2017-2022)
5.1.2 Global Viscosupplementation for Knee Osteoarthritis Forecasted Sales by Application (2023-2028)
5.1.3 Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2028)
5.2 Global Viscosupplementation for Knee Osteoarthritis Revenue by Application
5.2.1 Global Viscosupplementation for Knee Osteoarthritis Historical Revenue by Application (2017-2022)
5.2.2 Global Viscosupplementation for Knee Osteoarthritis Forecasted Revenue by Application (2023-2028)
5.2.3 Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Application (2017-2028)
5.3 Global Viscosupplementation for Knee Osteoarthritis Price by Application
5.3.1 Global Viscosupplementation for Knee Osteoarthritis Price by Application (2017-2022)
5.3.2 Global Viscosupplementation for Knee Osteoarthritis Price Forecast by Application (2023-2028)
6 North America
6.1 North America Viscosupplementation for Knee Osteoarthritis Market Size by Type
6.1.1 North America Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2028)
6.1.2 North America Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2028)
6.2 North America Viscosupplementation for Knee Osteoarthritis Market Size by Application
6.2.1 North America Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2028)
6.2.2 North America Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2028)
6.3 North America Viscosupplementation for Knee Osteoarthritis Market Size by Country
6.3.1 North America Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2028)
6.3.2 North America Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Viscosupplementation for Knee Osteoarthritis Market Size by Type
7.1.1 Europe Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2028)
7.1.2 Europe Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2028)
7.2 Europe Viscosupplementation for Knee Osteoarthritis Market Size by Application
7.2.1 Europe Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2028)
7.2.2 Europe Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2028)
7.3 Europe Viscosupplementation for Knee Osteoarthritis Market Size by Country
7.3.1 Europe Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2028)
7.3.2 Europe Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Viscosupplementation for Knee Osteoarthritis Market Size by Type
8.1.1 Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2028)
8.1.2 Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2028)
8.2 Asia Pacific Viscosupplementation for Knee Osteoarthritis Market Size by Application
8.2.1 Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2028)
8.2.2 Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2028)
8.3 Asia Pacific Viscosupplementation for Knee Osteoarthritis Market Size by Region
8.3.1 Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales by Region (2017-2028)
8.3.2 Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Viscosupplementation for Knee Osteoarthritis Market Size by Type
9.1.1 Latin America Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2028)
9.1.2 Latin America Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2028)
9.2 Latin America Viscosupplementation for Knee Osteoarthritis Market Size by Application
9.2.1 Latin America Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2028)
9.2.2 Latin America Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2028)
9.3 Latin America Viscosupplementation for Knee Osteoarthritis Market Size by Country
9.3.1 Latin America Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2028)
9.3.2 Latin America Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Market Size by Type
10.1.1 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2028)
10.1.2 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2028)
10.2 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Market Size by Application
10.2.1 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2028)
10.2.2 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2028)
10.3 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Market Size by Country
10.3.1 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2028)
10.3.2 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Viscosupplementation for Knee Osteoarthritis Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Anika Therapeutics
11.2.1 Anika Therapeutics Corporation Information
11.2.2 Anika Therapeutics Overview
11.2.3 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Anika Therapeutics Recent Developments
11.3 Seikagaku
11.3.1 Seikagaku Corporation Information
11.3.2 Seikagaku Overview
11.3.3 Seikagaku Viscosupplementation for Knee Osteoarthritis Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Seikagaku Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Seikagaku Recent Developments
11.4 Zimmer
11.4.1 Zimmer Corporation Information
11.4.2 Zimmer Overview
11.4.3 Zimmer Viscosupplementation for Knee Osteoarthritis Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Zimmer Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zimmer Recent Developments
11.5 Bioventus
11.5.1 Bioventus Corporation Information
11.5.2 Bioventus Overview
11.5.3 Bioventus Viscosupplementation for Knee Osteoarthritis Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bioventus Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bioventus Recent Developments
11.6 Ferring
11.6.1 Ferring Corporation Information
11.6.2 Ferring Overview
11.6.3 Ferring Viscosupplementation for Knee Osteoarthritis Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ferring Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ferring Recent Developments
11.7 Lifecore Biomedical
11.7.1 Lifecore Biomedical Corporation Information
11.7.2 Lifecore Biomedical Overview
11.7.3 Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lifecore Biomedical Recent Developments
11.8 LG Life Sciences
11.8.1 LG Life Sciences Corporation Information
11.8.2 LG Life Sciences Overview
11.8.3 LG Life Sciences Viscosupplementation for Knee Osteoarthritis Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 LG Life Sciences Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 LG Life Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Viscosupplementation for Knee Osteoarthritis Industry Chain Analysis
12.2 Viscosupplementation for Knee Osteoarthritis Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Viscosupplementation for Knee Osteoarthritis Production Mode & Process
12.4 Viscosupplementation for Knee Osteoarthritis Sales and Marketing
12.4.1 Viscosupplementation for Knee Osteoarthritis Sales Channels
12.4.2 Viscosupplementation for Knee Osteoarthritis Distributors
12.5 Viscosupplementation for Knee Osteoarthritis Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Viscosupplementation for Knee Osteoarthritis Industry Trends
13.2 Viscosupplementation for Knee Osteoarthritis Market Drivers
13.3 Viscosupplementation for Knee Osteoarthritis Market Challenges
13.4 Viscosupplementation for Knee Osteoarthritis Market Restraints
14 Key Findings in The Global Viscosupplementation for Knee Osteoarthritis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Viscosupplementation for Knee Osteoarthritis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Single Injection
    Table 3. Major Manufacturers of Three Injection
    Table 4. Major Manufacturers of Five Injection
    Table 5. Global Viscosupplementation for Knee Osteoarthritis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Viscosupplementation for Knee Osteoarthritis Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Viscosupplementation for Knee Osteoarthritis Sales by Region (2017-2022) & (K Units)
    Table 8. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Region (2017-2022)
    Table 9. Global Viscosupplementation for Knee Osteoarthritis Sales by Region (2023-2028) & (K Units)
    Table 10. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Region (2023-2028)
    Table 11. Global Viscosupplementation for Knee Osteoarthritis Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Region (2017-2022)
    Table 13. Global Viscosupplementation for Knee Osteoarthritis Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Region (2023-2028)
    Table 15. Global Viscosupplementation for Knee Osteoarthritis Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Viscosupplementation for Knee Osteoarthritis Sales Share by Manufacturers (2017-2022)
    Table 17. Global Viscosupplementation for Knee Osteoarthritis Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Viscosupplementation for Knee Osteoarthritis Revenue Share by Manufacturers (2017-2022)
    Table 19. Viscosupplementation for Knee Osteoarthritis Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Viscosupplementation for Knee Osteoarthritis Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Viscosupplementation for Knee Osteoarthritis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viscosupplementation for Knee Osteoarthritis as of 2021)
    Table 22. Viscosupplementation for Knee Osteoarthritis Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Viscosupplementation for Knee Osteoarthritis Product Offered
    Table 24. Date of Manufacturers Enter into Viscosupplementation for Knee Osteoarthritis Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2022) & (K Units)
    Table 27. Global Viscosupplementation for Knee Osteoarthritis Sales by Type (2023-2028) & (K Units)
    Table 28. Global Viscosupplementation for Knee Osteoarthritis Sales Share by Type (2017-2022)
    Table 29. Global Viscosupplementation for Knee Osteoarthritis Sales Share by Type (2023-2028)
    Table 30. Global Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Viscosupplementation for Knee Osteoarthritis Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Viscosupplementation for Knee Osteoarthritis Revenue Share by Type (2017-2022)
    Table 33. Global Viscosupplementation for Knee Osteoarthritis Revenue Share by Type (2023-2028)
    Table 34. Viscosupplementation for Knee Osteoarthritis Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Viscosupplementation for Knee Osteoarthritis Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2022) & (K Units)
    Table 37. Global Viscosupplementation for Knee Osteoarthritis Sales by Application (2023-2028) & (K Units)
    Table 38. Global Viscosupplementation for Knee Osteoarthritis Sales Share by Application (2017-2022)
    Table 39. Global Viscosupplementation for Knee Osteoarthritis Sales Share by Application (2023-2028)
    Table 40. Global Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Viscosupplementation for Knee Osteoarthritis Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Viscosupplementation for Knee Osteoarthritis Revenue Share by Application (2017-2022)
    Table 43. Global Viscosupplementation for Knee Osteoarthritis Revenue Share by Application (2023-2028)
    Table 44. Viscosupplementation for Knee Osteoarthritis Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Viscosupplementation for Knee Osteoarthritis Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2022) & (K Units)
    Table 47. North America Viscosupplementation for Knee Osteoarthritis Sales by Type (2023-2028) & (K Units)
    Table 48. North America Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Viscosupplementation for Knee Osteoarthritis Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2022) & (K Units)
    Table 51. North America Viscosupplementation for Knee Osteoarthritis Sales by Application (2023-2028) & (K Units)
    Table 52. North America Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Viscosupplementation for Knee Osteoarthritis Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2022) & (K Units)
    Table 55. North America Viscosupplementation for Knee Osteoarthritis Sales by Country (2023-2028) & (K Units)
    Table 56. North America Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Viscosupplementation for Knee Osteoarthritis Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Viscosupplementation for Knee Osteoarthritis Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Viscosupplementation for Knee Osteoarthritis Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Viscosupplementation for Knee Osteoarthritis Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Viscosupplementation for Knee Osteoarthritis Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Viscosupplementation for Knee Osteoarthritis Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Viscosupplementation for Knee Osteoarthritis Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Viscosupplementation for Knee Osteoarthritis Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Viscosupplementation for Knee Osteoarthritis Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Viscosupplementation for Knee Osteoarthritis Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Viscosupplementation for Knee Osteoarthritis Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Viscosupplementation for Knee Osteoarthritis Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Viscosupplementation for Knee Osteoarthritis Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Sanofi Corporation Information
    Table 107. Sanofi Description and Major Businesses
    Table 108. Sanofi Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Sanofi Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Sanofi Recent Developments
    Table 111. Anika Therapeutics Corporation Information
    Table 112. Anika Therapeutics Description and Major Businesses
    Table 113. Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Anika Therapeutics Recent Developments
    Table 116. Seikagaku Corporation Information
    Table 117. Seikagaku Description and Major Businesses
    Table 118. Seikagaku Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Seikagaku Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Seikagaku Recent Developments
    Table 121. Zimmer Corporation Information
    Table 122. Zimmer Description and Major Businesses
    Table 123. Zimmer Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Zimmer Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Zimmer Recent Developments
    Table 126. Bioventus Corporation Information
    Table 127. Bioventus Description and Major Businesses
    Table 128. Bioventus Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Bioventus Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Bioventus Recent Developments
    Table 131. Ferring Corporation Information
    Table 132. Ferring Description and Major Businesses
    Table 133. Ferring Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Ferring Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Ferring Recent Developments
    Table 136. Lifecore Biomedical Corporation Information
    Table 137. Lifecore Biomedical Description and Major Businesses
    Table 138. Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Lifecore Biomedical Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Lifecore Biomedical Recent Developments
    Table 141. LG Life Sciences Corporation Information
    Table 142. LG Life Sciences Description and Major Businesses
    Table 143. LG Life Sciences Viscosupplementation for Knee Osteoarthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. LG Life Sciences Viscosupplementation for Knee Osteoarthritis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. LG Life Sciences Recent Developments
    Table 146. Key Raw Materials Lists
    Table 147. Raw Materials Key Suppliers Lists
    Table 148. Viscosupplementation for Knee Osteoarthritis Distributors List
    Table 149. Viscosupplementation for Knee Osteoarthritis Customers List
    Table 150. Viscosupplementation for Knee Osteoarthritis Market Trends
    Table 151. Viscosupplementation for Knee Osteoarthritis Market Drivers
    Table 152. Viscosupplementation for Knee Osteoarthritis Market Challenges
    Table 153. Viscosupplementation for Knee Osteoarthritis Market Restraints
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Viscosupplementation for Knee Osteoarthritis Product Picture
    Figure 3. Global Viscosupplementation for Knee Osteoarthritis Market Share by Type in 2021 & 2028
    Figure 3. Single Injection Product Picture
    Figure 4. Three Injection Product Picture
    Figure 5. Five Injection Product Picture
    Figure 6. Global Viscosupplementation for Knee Osteoarthritis Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Clinics
    Figure 9. Others
    Figure 10. Viscosupplementation for Knee Osteoarthritis Report Years Considered
    Figure 11. Global Viscosupplementation for Knee Osteoarthritis Sales 2017-2028 (K Units)
    Figure 12. Global Viscosupplementation for Knee Osteoarthritis Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Viscosupplementation for Knee Osteoarthritis Revenue 2017-2028 (US$ Million)
    Figure 14. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Region (2017-2022)
    Figure 16. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Region (2023-2028)
    Figure 17. North America Viscosupplementation for Knee Osteoarthritis Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Viscosupplementation for Knee Osteoarthritis Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Viscosupplementation for Knee Osteoarthritis Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Viscosupplementation for Knee Osteoarthritis Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Viscosupplementation for Knee Osteoarthritis Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Viscosupplementation for Knee Osteoarthritis Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Viscosupplementation for Knee Osteoarthritis Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Viscosupplementation for Knee Osteoarthritis Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Viscosupplementation for Knee Osteoarthritis Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Viscosupplementation for Knee Osteoarthritis Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Viscosupplementation for Knee Osteoarthritis in the World: Market Share by Viscosupplementation for Knee Osteoarthritis Revenue in 2021
    Figure 29. Global Viscosupplementation for Knee Osteoarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2028)
    Figure 31. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Type (2017-2028)
    Figure 32. Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2028)
    Figure 33. Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Application (2017-2028)
    Figure 34. North America Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2028)
    Figure 35. North America Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Type (2017-2028)
    Figure 36. North America Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2028)
    Figure 37. North America Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Application (2017-2028)
    Figure 38. North America Viscosupplementation for Knee Osteoarthritis Sales Share by Country (2017-2028)
    Figure 39. North America Viscosupplementation for Knee Osteoarthritis Revenue Share by Country (2017-2028)
    Figure 40. U.S. Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2028)
    Figure 43. Europe Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2028)
    Figure 45. Europe Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Viscosupplementation for Knee Osteoarthritis Sales Share by Country (2017-2028)
    Figure 47. Europe Viscosupplementation for Knee Osteoarthritis Revenue Share by Country (2017-2028)
    Figure 48. Germany Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 49. France Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue Share by Region (2017-2028)
    Figure 59. China Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 62. India Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Viscosupplementation for Knee Osteoarthritis Sales Share by Country (2017-2028)
    Figure 74. Latin America Viscosupplementation for Knee Osteoarthritis Revenue Share by Country (2017-2028)
    Figure 75. Mexico Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue Share by Country (2017-2028)
    Figure 84. Turkey Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Viscosupplementation for Knee Osteoarthritis Revenue (2017-2028) & (US$ Million)
    Figure 87. Viscosupplementation for Knee Osteoarthritis Value Chain
    Figure 88. Viscosupplementation for Knee Osteoarthritis Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global Kidney Cancer Therapeutics Market Research Report 2022
Global Kidney Cancer Therapeutics Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-4Y11866
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Lisinopril Tablets Market Research Report 2022
Global Lisinopril Tablets Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-4W11860
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Lisinopril API Market Research Report 2022
Global Lisinopril API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-3X11853
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Peripheral Nerve Injuries Market Research Report 2022
Global Peripheral Nerve Injuries Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-28R11418
Fri Aug 12 00:00:00 UTC 2022

Add to Cart